knowledge -WSS

knowledge

author：leisure time 2025-10-03 00:07:49 - browse：547

Eli Lilly headquarters in Indianapolis – pharmaceutical coverage from STAT — Darron Cummings/AP

LONDON — A U.K. government agency on Tuesday said that it won’t recommend Eli Lilly’s Mounjaro — part of a new class of medications that help patients lose weight — for people with type 2 diabetes without additional evidence.

Mounjaro, also known as tirzepatide, has U.S. approval for type 2 diabetes and is expected to win the regulatory green light for obesity later this year. It is one of several medications, along with Wegovy and Ozempic from Novo Nordisk, that have shown dramatic weight loss results, creating a surge in demand and blockbuster sales expectations.

But in draft guidance, the U.K.’s National Institute for Health and Care Excellence, which assesses the cost-effectiveness of medications, said it had asked Lilly for more data “to address the uncertainties in the clinical evidence, when compared to all relevant alternative treatments.” NICE recommendations are used by the National Health Service to determine whether to provide certain medications.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： Pushing for an NIH office for post

knowledge

WSS

New lawsuit accuses health insurer Cigna of denying claims in bulk

Ebola: Gilead Sciences antiviral shows promise as new treatment

'Investigate these claims': UFO transparency at center of House hearing

How many hemophilia patients actually want gene therapy?

Roche’s Alnylam deal shows drug firms interested in heart drugs

What to watch for from Zogenix and Amicus clinical trials

hotspot

knowledge

knowledge

Anesthesiologist group: stop taking Ozempic before surgery

Biden warns of ‘dark winter’ during final presidental debate

Anesthesiologist group: stop taking Ozempic before surgery

Male and female sex labels in research insufficient, scientists say

Anesthesiologist group: stop taking Ozempic before surgery

Bronny James, LeBron's son, suffers cardiac arrest during basketball practice at USC

What does generative AI mean for health care? We asked experts

Readout LOUD podcast: ALS dilemma, first MASH drug, and more

Anesthesiologist group: stop taking Ozempic before surgery

What to watch for from Zogenix and Amicus clinical trials

Wikipedia

New lawsuit accuses health insurer Cigna of denying claims in bulk

FDA advisers back CAR

Why scientists need input from humanists on sensitive research

Amid AI frenzy, a top HHS official's quest to create safeguards

As AI in medicine takes off, can 'human in the loop' prevent harm?

New Alzheimer's drugs heat up race for early detection blood tests

hotspot

focus

knowledge

explore